News | July 05, 2025
European Commission fines Alchem for participating in API cartel
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Changhua site meets international regulatory standards for global medical applications
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival - three times longer than R-GemOx
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Subscribe To Our Newsletter & Stay Updated
